当前位置：
X-MOL 学术
›
Ophthalmology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution
Ophthalmology ( IF 13.1 ) Pub Date : 2024-09-16 , DOI: 10.1016/j.ophtha.2024.09.010 Jay S Pepose 1 , David Wirta 2 , David Evans 3 , Barbara Withers 4 , Kavon Rahmani 5 , Audrey Lazar 4 , Drey Coleman 4 , Ronil Patel 4 , Reda Jaber 4 , Mina Sooch 4 , Mitchell Brigell 4 , Konstantinos Charizanis 4
Ophthalmology ( IF 13.1 ) Pub Date : 2024-09-16 , DOI: 10.1016/j.ophtha.2024.09.010 Jay S Pepose 1 , David Wirta 2 , David Evans 3 , Barbara Withers 4 , Kavon Rahmani 5 , Audrey Lazar 4 , Drey Coleman 4 , Ronil Patel 4 , Reda Jaber 4 , Mina Sooch 4 , Mitchell Brigell 4 , Konstantinos Charizanis 4
Affiliation
To evaluate the safety and efficacy of 0.75% phentolamine ophthalmic solution (POS), an α-adrenergic antagonist, in reversal of pharmacologically induced mydriasis.
中文翻译：
酚妥拉明滴眼液逆转药理学诱导的瞳孔散大
评价 0.75% 酚妥拉明滴眼液 （POS）（一种 α-肾上腺素能拮抗剂）逆转药理学诱导的瞳孔散大的安全性和有效性。
更新日期：2024-09-16
中文翻译：
酚妥拉明滴眼液逆转药理学诱导的瞳孔散大
评价 0.75% 酚妥拉明滴眼液 （POS）（一种 α-肾上腺素能拮抗剂）逆转药理学诱导的瞳孔散大的安全性和有效性。
京公网安备 11010802027423号